Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

539 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
IDH-mutant myeloid neoplasms are associated with seronegative rheumatoid arthritis and innate immune activation.
Hong LE, Wechalekar MD, Kutyna M, Small A, Lim K, Thompson-Peach C, Li JJ, Chhetri R, Scott HS, Brown A, Hahn CN, Yeung DT, Sajid S, Robinson N, Thomas R, Branford S, D'Andrea RJ, Samaraweera SE, Patnaik M, Proudman S, Thomas D, Kok CH, Shah MV, Hiwase DK. Hong LE, et al. Among authors: patnaik m. Blood. 2024 May 2;143(18):1873-1877. doi: 10.1182/blood.2023023593. Blood. 2024. PMID: 38457663 Free article.
Bone marrow dendritic cell aggregates associate with systemic immune dysregulation in chronic myelomonocytic leukemia.
Mangaonkar AA, Reichard KK, Binder M, Coltro G, Lasho TL, Carr RM, Chiu A, Negron V, Hefazi M, Anagnostou T, Timm MM, Hiebert JW, Villasboas JC, Gonsalves WI, Gangat N, Shah M, Alkhateeb HB, Al-Kali A, Elliott MA, Begna KH, Wolanskyj-Spinner AP, Litzow MR, Hogan WJ, Ansell SM, Pardanani A, Tefferi A, Patnaik MM. Mangaonkar AA, et al. Among authors: patnaik mm. Blood Adv. 2020 Nov 10;4(21):5425-5430. doi: 10.1182/bloodadvances.2020002415. Blood Adv. 2020. PMID: 33152058 Free PMC article.
Prognostic impact and timing considerations for allogeneic hematopoietic stem cell transplantation in chronic myelomonocytic leukemia.
Pophali P, Matin A, Mangaonkar AA, Carr R, Binder M, Al-Kali A, Begna KH, Reichard KK, Alkhateeb H, Shah MV, Tefferi A, Hogan WJ, Litzow MR, Patnaik MM. Pophali P, et al. Among authors: patnaik mm. Blood Cancer J. 2020 Nov 20;10(11):121. doi: 10.1038/s41408-020-00387-y. Blood Cancer J. 2020. PMID: 33219206 Free PMC article. Clinical Trial. No abstract available.
Treatment outcome of clonal cytopenias of undetermined significance: a single-institution retrospective study.
Xie Z, Nanaa A, Saliba AN, He R, Viswanatha D, Nguyen P, Jevremovic D, Greipp P, Salama ME, Gangat N, Alkhateeb HB, Tefferi A, Litzow M, Patnaik M, Shah M, Al-Kali A. Xie Z, et al. Among authors: patnaik m. Blood Cancer J. 2021 Mar 1;11(3):43. doi: 10.1038/s41408-021-00439-x. Blood Cancer J. 2021. PMID: 33649321 Free PMC article. No abstract available.
Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation.
Joshi M, Cook J, McCullough K, Nanaa A, Gangat N, Foran JM, Murthy HS, Kharfan-Dabaja MA, Sproat L, Palmer J, Pardanani A, Tefferi A, Begna K, Elliot M, Al-Kali A, Patnaik M, Shah MV, Hogan WJ, Litzow MR, Alkhateeb HB. Joshi M, et al. Among authors: patnaik m. Blood Cancer J. 2021 Mar 4;11(3):49. doi: 10.1038/s41408-021-00437-z. Blood Cancer J. 2021. PMID: 33664234 Free PMC article. No abstract available.
Clinical, molecular, and prognostic comparisons between CCUS and lower-risk MDS: a study of 187 molecularly annotated patients.
Li M, Binder M, Lasho T, Ferrer A, Gangat N, Al-Kali A, Mangaonkar A, Elliott M, Litzow M, Hogan W, Pardanani A, Wolanskyj-Spinner A, Howard M, King RL, Shah M, Alkhateeb H, Begna K, Tefferi A, Finke C, Oliveira J, Ketterling R, Olteanu H, Patnaik MM. Li M, et al. Among authors: patnaik mm. Blood Adv. 2021 Apr 27;5(8):2272-2278. doi: 10.1182/bloodadvances.2020003976. Blood Adv. 2021. PMID: 33904893 Free PMC article. No abstract available.
539 results